Target Name: ZNF236
NCBI ID: G7776
Review Report on ZNF236 Target / Biomarker Content of Review Report on ZNF236 Target / Biomarker
ZNF236
Other Name(s): zinc finger protein 236 | Zinc finger protein 236, transcript variant 1 | ZNF236B | ZNF236 variant 1 | Zinc finger protein 236 (isoform 1) | ZNF236A | Regulated by glucose | regulated by glucose | ZN236_HUMAN | Zinc finger protein 236 | ZNF236 variant 2 | Zinc finger protein 236, transcript variant 2 | Zinc finger protein 236 (isoform 2)

ZNF236: A Potential Drug Target and Biomarker forfungal Infections

Fungal infections are a common pathology that affect millions of people worldwide and can cause a range of symptoms from mild to severe. fungal infections are caused by the fungus, which is a type of microorganism that grows from a single cell. The fungus can invade various parts of the body, including the skin, nail, and respiratory tract. Fungal infections can be treated with various drugs, but there is a growing need for new and more effective treatments to combat these infections. One potential drug target and biomarker for fungal infections is ZNF236, a protein that is expressed in a variety of organisms, including humans.

ZNF236: A protein that is expressed in many organisms

ZNF236 is a protein that is expressed in many organisms, including humans. It is a member of the ZNF2 gene family, which is a family of proteins that are characterized by the presence of a zinc finger. ZNF236 is unique because it is a type of zinc finger protein that is expressed in many organisms, including humans. The zinc finger is a structural protein that contains a zinc atom, which can interact with various molecules.

ZNF236 plays a role in various biological processes

ZNF236 is involved in various biological processes that are important for human health. For example, ZNF236 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also involved in the regulation of cellular processes that are important for growth, development, and survival.

In addition to its role in biology, ZNF236 has also been shown to be a potential drug target. The zinc finger protein has been shown to interact with various molecules, including transcription factors, which are proteins that control the expression of genes. This suggests that ZNF236 could be a drug target by itself or that it could be a useful biomarker for identifying patients who are respond to antifungal therapy.

The potential benefits of ZNF236 as a drug target

If ZNF236 is successfully targeted as a drug, it has the potential to treat a wide range of fungal infections. Currently, there are few effective treatments available for fungal infections, which can be a serious and life-threatening condition. The development of new and more effective treatments for fungal infections is a priority for the medical community.

In addition to its potential as a drug, ZNF236 has the potential to be a biomarker for fungal infections. The zinc finger protein is expressed in a variety of organisms, including humans, and has been shown to play a role in the development and progression of various diseases. By studying the expression and function of ZNF236, researchers may be able to identify new biomarkers for fungal infections.

Conclusion

In conclusion, ZNF236 is a protein that is expressed in many organisms, including humans, and has the potential to be a drug target and biomarker for fungal infections. Further research is needed to fully understand the role of ZNF236 in biology and to explore its potential as a drug.

Protein Name: Zinc Finger Protein 236

Functions: May be involved in transcriptional regulation

The "ZNF236 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF236 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A